Juvenescence
PrivateLast Round
Series B
Extension
May 21, 2025
Est. Valuation
$500M
Total Funding Raised
$163M
Company Overview
Juvenescence is a biotechnology company that develops medicines and therapies designed to extend healthy human lifespan by targeting the core mechanisms of aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, D2C Brands, Sports & Fitness
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juvenescence Comparables
Compare Juvenescence with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cambrian Bio | 87% | |
| BioAge Labs | 78% | |
| Altos Labs | 77% | |
Juvenescence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 21, 2025 | ||||
| Series B | Aug 19, 2019 | ||||
| Series A | Jun 11, 2018 | ||||
| Seed | Jan 8, 2018 |
Key People
Founding team and executive leadership
Juvenescence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Grok Ventures | Series B |
| IPGL | Series B |
| SEED Innovations Limited | Series A |
| Apeiron Investment Group | Seed |
| Foresite Capital | Seed |
| Oryx Ventures | Series B |
| SEED Innovations | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2025
Attended the Middle East Investors Summit in Abu Dhabi.
- Jun 5, 2025
Acquired Ro5 Inc. for $76 million.
Juvenescence Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Juvenescence's valuation, stock price, and market status.